Health ❯ Healthcare ❯ Biotechnology ❯ Drug Development

Clinical Research

MoonLake Investors Face Dec. 15 Lead-Plaintiff Deadline in SDNY Securities Case

Investors have until December 15, 2025 to seek lead-plaintiff status in the SDNY case alleging misstatements about sonelokimab's touted Nanobody advantages.